TTFields also modulated the hypercoagulable phenotype of GBM cells by suppressing A2M expression and upregulating plasminogen activator genes, both of which influence coagulation and fibrinolysis but may also facilitate tumor cell migration. Here, A2M is linked to glioblastoma.